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ABSTRACT
Objective: To determine the baseline pattern and audit management modalities of chronic
osteomyelitis in patients with sickle cell disease.
Design: A retrospective study.
Setting: Jos University Teaching Hospital, Jos, Nigeria from August 1993 to July 1997.
Patients: Twenty four patients with concomitant chronic sickle cell disease.
Interventions: Fifteen patients had operations; eleven had sequestrectomy and curettage while
four had incision and drainage. Eight patients were treated with antibiotics alone and one
patient refused surgery.
Main outcome measures: The demographic data of patients, aetiological agents, culture and
sensitivity patterns, aetiopathogenesis, treatment modalities and outcome were analysed.
Results: Twenty four (36.9%) out of 65 patients who had chronic osteomyelitis also had sickle
cell disease. Male:female ratio was 1.2:1. The peak age incidence (37.5%) was in the first
decade of life. Seventy five per cent of infections were haematogenous. The most frequently
isolated organism was Staphylococcus aureus (58.8%) while the rest were Gram negative
organisms. There was no case of Salmonella osteomyelitis. The most sensitive antibiotics were
gentamicin and the third generation cephalosporins. Twelve patients (50%) had good results
while eight (33.3%) were still undergoing treatment. Complications recorded were persistent
discharging sinuses in two cases, recurrence of symptoms in one and pathological fracture
with non-union in one patient.
Conclusion: Though the incidence of Gram negative organisms in causation of chronic
osteomyelitis in patients who have sickle cell disease is high (41.2%), Salmonella osteomyelitis
may be related to endemicity of the organism in a given locality.
INTRODUCTION
The manifestations of sickle cell disease in the
musculoskeletal system are major causes of morbidity
and disability in West and Central Africa, the
Mediterranean and in the West Indies(1). The vaso-
occlusive phenomenon leads to bone infarction and
relapsing bone pain crisis. Also, avascular necrosis of
major bone parts, for example, femoral and humeral
heads result in subsequent joint degeneration. Whereas
hypertrophy of bone marrow a a result of increased
haemopoietic demand leads to cortical thinning and
osteoporosis; this consequently predisposes the patient
to pathological fractures and hand-foot syndrome
(dactylitis). Furthermore, there is reduced immunity in
patients who have sickle cell disease as a result of
splenic hypofunction and defective opsonins(2). In the
presence of infarcted bone tissue, there is an increase
in the risk of osteomyelitis. The patients become
susceptible to unusual organisms as was reported in the
series by Ebong(3,4) in Ibadan and Givner et al(5) in
which a preponderance of salmonella osteomyelitis was
found among patients who had concomitant sickle cell
disease. The morbidity of chronic osteomyelitis
combined with other effects of the haemoglobinopathy
decreases the quality of life. It is worth pointing out
that sickle cell disease here is applied to sickle cell
anaemia (haemoglobin SS), sickle cell trait (haemoglobin
AS), beta-thalasaemia, haemoglobin SC, and any other
condition in which the sickle cell haemoglobin is
combined with other abnormal forms of haemoglobin (6).
We have retrospectively reviewed patients who had
chronic osteomyelitis and sickle cell disease in Jos
University Teaching Hospital over a four-year period
with a view to determining the pattern and audit
management modalities. This study would also furnish
a baseline for further comparative and specific studies
on chronic osteomyelitis in this centre.
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MATERIALS AND METHODS
Twenty four patients who had sickle cell disease and
presented to Jos University Teaching Hospital with concomitant
chronic osteomyelitis over a four-year period from August
1993 to July 1997 were retrospectively studied. The patients
were identified from the ward admission and discharge
records and the operating register and the case notes obtained
from the Health Record retrieval system. The information was
analysed for age, sex, investigation, treatment and follow up.
The diagnosis was made on the basis of both clinical and
radiological findings. The sickle cell disease was confirmed
by electrophoresis after routine sickling test had proved
positive. Chronic osteomyelitis was diagnosed in the presence
of swelling, pain, discharging sinuses, peculiarly-looking
healed adherent scars and x-ray findings of sequestra, abscess
cavity, irregular sclerosis and osteolytic bone changes and
periosteal reaction. Wound swabs and aspirates from swollen
areas were routinely sent for microscopy, culture and
sensitivity. Anaerobic culture was not done on any of the
patients because of lack of facilities at the study centre.
Antibiotics were administered at first empirically then following
culture and sensitivity results and were continued until
healing or changed according to laboratory result.
Sequestrectomy and curettage were offered as treatment if
a mature sequestrum or abscess cavity was seen on  x-ray
and incision and drainage for fluctuant soft tissue abscesses.
Dressing was done using hydrogen peroxide and Eusol and
the frequency determined by the extent of tissue necrosis and
discharge. The result was regarded as good or healing said
to have occurred if after operation or a course of antibiotics,
the wound remained dry and closed, and pain subsided with
no further radiological sign of sequestrum or abscess.
RESULTS
In the four-year period under review, 65 cases of
chronic osteomyelitis were treated at the Jos University
Teaching Hospital. Of these, 24 (36.9%) patients had
concomitant sickle cell disease. There were 13 males
and eleven females giving a male: female ratio of
1.2:1.0. The incidence of chronic osteomyelitis in
patients who had sickle cell disease was therefore six
new cases per year.
The ages ranged from one year three months to 35
years with the peak age incidence in the first decade of
life (37.5%). This was followed closely by patients in
the second decade (33.3%) and 25% in the third decade
of life. Only one (4.1%) patient was over 30 years.
Fourteen of the patients presented within the first
six months of having symptoms. Of these, nine patients
reported in the first month. One patient presented in
first year and two in the second year. Four patients were
seen after two years while in three patients, there were
no records of duration of symptoms.
The foci of infection were found in 27 bones as
shown in Table 1. The tibia was the most frequently
involved bone (40%). Three patients had multiple foci
of infection. Outside the long bones, the thoracolumbar
spine was affected twice, the left side of mandible once,
and the first left metatarsal bone once. The two cases
of spinal involvement had concomitant tuberculosis.
Table 1
Anatomical sites of the lesions






First metatarsal 1 3.7
Spine 2 7.4
Total 27
Three patients had multiple bone involvement
Fifteen operations were carried out. Of these, four
incisions and drainage were done, and eleven patients
had sequestrectomy and curettage. One patient could
not afford the cost of surgery and in eight cases,
operation was not indicated and were treated with
antibiotics.
In 18 (75%) patients, infection was haematogenous,
but followed traumatic injury in five cases (20.8%). In
one patient, chronic osteomyelitis was a result of direct
extension from a chronic leg ulcer. The traumatic
injuries were as a result of compound fractures from
falls and road traffic accidents.
At the time of presentation, six patients (25%) were
known sicklers under treatment whereas 18 (75%) were
diagnosed as having sickle cell disease while under
treatment. Fourteen (58.4%) of the patients had sickle
cell anaemia (haemoglobin SS disease), eight (33.3%)
had the sickle cell trait (haemoglobin AS) and two
(8.4%) had haemoglobin SC. There was no case of beta
thalasaemia.
Seventeen positive cultures were obtained from 14
patients. The cultural characteristics of the aetiological
agents is shown in Table 2. Staphylococcus aureus was
the most frequently isolated organism in 58.8% cases.
Mixed infection occurred in three cases. Two patients had
secondary infection of tuberculosis of the spine. There
was either no growth or no record of any culture in 10
patients. No case of salmonella osteomyelitis was found.
Table 2
Culture characteristics of the aetiological organisms
Organism No. of times cultured %
Staphylococcus aureus 10 58.8
Pseudomonas aeruginosa 1 5.9
Klebsiella species 2 11.8
Citrobacter fruendi 1 5.9
Escherichia coli 2 11.8
Proteus species 1 5.9
Total 17 positive growths
No growth or not done in 10 patients
The in vitro sensitivity pattern of the isolated
organisms in shown in Table 3. Gentamicin and the
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third generation cephalosporins were the most sensitive
antibiotics. This was followed by erythromycin and
tetracycline. Sensitivity to cloxacillin was relatively low
(6.5%).
Table 3
In-vitro sensitivity pattern of isolated organisms to antibiotics



















Duration of follow up










The duration of follow up of the patients is shown
in Table 4. Of the 12 patients who were followed up
for one year or less, eight were still under treatment.
Twelve patients were found to have no recurrence of
symptoms and were considered to have good results.
We recorded complications of persistent discharging
sinuses in two cases, recurrence of symptoms in one
and pathological fracture with non-union in one patient.
No death was recorded in the period of study.
DISCUSSION
It was observed that 36.9% of sixty five patients
treated for chronic osteomyelitis during the study period
had concomitant sickle cell disease. This high figure
is not surprising, as osteomyelitis is known to be
common in sicklers(7-10). The vaso-occlusive crisis
that results in frequent bone infarction, coupled with
reduced immunity, contributed to the high incidence.
Bone tissue is usually resistant to infection and only
gets overcome by organisms of high virulence, in the
presence of foreign body and when there is decreased
host resistance(7).
Our finding of a preponderance of chronic
osteomyelitis in the younger age group in this study
conforms with the known fact that it is usually a disease
of children(1-10). The oldest patient was aged 35 years.
This could be accounted for by the low life expectancy
in sickle cell anaemia. In sickle cell trait, with normal
life expectancy, absence of older patients is explained
by the relative less susceptibility of adult bones to
infection(7). In addition, the study period was a time
of severe economic depression in Nigeria when hunger
and malnutrition were prevalent. This could have
contributed to reduced host immunity in the more
vulnerable age group. Haematogenous spread of infection
which was observed in 75% of the patients in this series
is directly related to reduced host immunity(1,7,9,10).
There were 27 bones affected in twenty four
patients. Only three patients had double bone
involvement. This finding contrasts with previously
held view that chronic osteomyelitis usually involves
multiple bones in patients who have sickle cell
disease(2,5,6,10).
Staphylococcus aureus was the leading causative
organism accounting for 58.8% of the cases with
positive culture. There was no case of salmonella
osteomyelitis even though the remaining 41.2% were
caused by gram negative organisms. Givner et al. (5)
in a pulled study involved 84 patients with sickle cell
disease isolated salmonella in 74% and Staphylococcus
in ten per cent of the positive cultures(2).
In a study of children in Ibadan, Nigeria, Ebong
found a preponderance of salmonella osteomyelitis
which he attributed to endemicity of the organism in
the environment(2,3). Another study in Enugu, Nigeria,
found the most frequent aetiological agent of
osteomyelitis among sicklers to be Staphylococcus
aureus in 50% of 18 patients(2). These studies were
carried out in the southern part of Nigeria with different
climatic condition from Jos, which is situated in the
savannah zone. Even though enteric fever is not a rarity
in this environment, absence of salmonella osteomyelitis
among sicklers would require a much larger series to
elucidate. In the general population, Staphylococcus
accounts for upto 80% of chronic osteomyelitis(9).
We note that there was high sensitivity to gentamicin
and the cephalosporins in 41.3% of isolates with relatively
low sensitivity to cloxacillin (6.5%). The tendency to
abuse cloxacillin in self medication in this locality is
enhanced by easy procurement, cheapness and the oral
route of administration. The laws restricting acquisition
of drugs via prescription is not strictly enforced. The
cephalosporins and gentamicin are less likely to be
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abused because of parenteral administration and high
cost.
In conclusion, we observe that the pattern of
chronic osteomyelitis in patients who have sickle cell
disease vary according to prevailing circumstances. The
peculiarity of a given locality needs to be determined
by regular audit. In this environment, the incidence of
Gram negative osteomyelitis is high. This, coupled with
low sensitivity to cloxacillin makes gentamicin,
cephalosporins and erythromycin the initial choice of
antibiotic treatment. The changing pattern of sensitivity
can only be determined by periodic review.
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